PortViewPortView
Cutera logo

Cutera (CUTR) Stock Analysis

NASDAQHealthcareMedical - Devices

$0.10+0.00%
1-year price historyRange $0.01 – $2.86
52-week range$0.10
$0.01$3.00

What Cutera does

Cutera, Inc. is a medical technology enterprise specializing in the research, development, manufacturing, marketing, and servicing of cutting-edge laser and energy-based aesthetic systems for medical professionals worldwide. The company's comprehensive product line includes several advanced devices: Secret PRO, an innovative system combining fractional CO2 technology for thorough skin resurfacing with radio frequency (RF) microneedling for deep dermal tissue restructuring. truSculpt flex, a bio-electrical muscle stimulation apparatus engineered to support individuals across all fitness capabilities. excel V+, a versatile platform designed for addressing vascular and benign pigmented lesions. truSculpt iD, specifically tailored for the non-invasive body contouring sector. Secret RF, a fractional RF microneedling system that promotes precise tissue coagulation and hemostasis. Cutera also provides robust multi-application platforms: The enlighten platform, a laser system highly effective for tattoo removal, as well as treating benign pigmented lesions and acne scarring. The excel HR platform, offering an extensive hair removal solution compatible with diverse skin types. The xeo platform, a adaptable system where users can acquire various handpiece attachments to manage unwanted hair, treat vascular lesions, and achieve overall skin revitalization by targeting discoloration, fine lines, and laxity. In addition to its device offerings, Cutera distributes a range of skincare products and delivers post-warranty support, accessible via extended service agreements or direct billing. The company supplies specialized pulsed light handpieces for treating discoloration, facilitating hair removal, and managing vascular conditions. It further offers Pearl and Pearl Fractional handpieces, along with essential consumables such as handpiece refills, cycle refills, consumable tips, and marketing materials, all available for purchase through its official website. Cutera's products are marketed and sold through a direct sales team, reaching a wide spectrum of medical and aesthetic professionals. This includes plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, other certified practitioners, and even medical doctors performing aesthetic procedures in non-clinical environments. Founded in 1988, Cutera, Inc. maintains its corporate headquarters in Brisbane, California.

Key metrics

Market cap
$1.96M
P/E (TTM)
-0.01
EPS (TTM)
$-7.18
Beta
1.37
Dividend yield
0.00%
Revenue / share
$10.68
50-day avg
$0.36
200-day avg
$0.71
52-week high
$3.00
52-week low
$0.01
CEO
Taylor C. Harris

ETFs linked to CUTR

Broad-market and Healthcare sector ETFs an investor holding Cutera is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CUTR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CUTR in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Cutera?
Cutera trades under the ticker CUTR on NASDAQ.
Which exchange is CUTR listed on?
CUTR is listed on NASDAQ.
What sector does Cutera operate in?
Cutera is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze CUTR in a portfolio?
PortView shows CUTR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.